世界の黄斑変性症治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Macular Degeneration Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12444 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、黄斑変性症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。黄斑変性症治療の種類別市場規模（ルセンティス、アイリーア、アバスチン、その他）、用途別市場規模（病院、眼科クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・黄斑変性症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bausch Health Companies、Allergan、Novartis、Pfizer、Bayer、Roche、Sanofi、Santen Pharmaceuticals、Regeneron Pharmaceuticals、Kanghong Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ルセンティス、アイリーア、アバスチン、その他 ・用途別分析2016年-2026年：病院、眼科クリニック、その他 ・黄斑変性症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・黄斑変性症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・黄斑変性症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・黄斑変性症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・黄斑変性症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Macular Degeneration Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Macular Degeneration Treatment size is estimated to be USD 7011.7 million in 2026 from USD 6123.2 million in 2020, with a change XX% between 2020 and 2021. The global Macular Degeneration Treatment market size is expected to grow at a CAGR of 3.4% for the next five years.

Market segmentation
Macular Degeneration Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Lucentis
Eylea
Avastin
Others

Market segment by Application, can be divided into
Hospitals
Eye Clinics
Others

Market segment by players, this report covers
Bausch Health Companies
Allergan
Novartis
Pfizer
Bayer
Roche
Sanofi
Santen Pharmaceuticals
Regeneron Pharmaceuticals
Kanghong Pharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Macular Degeneration Treatment
1.2 Classification of Macular Degeneration Treatment by Type
1.2.1 Overview: Global Macular Degeneration Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Macular Degeneration Treatment Revenue Market Share by Type in 2020
1.2.3 Lucentis
1.2.4 Eylea
1.2.5 Avastin
1.2.6 Others
1.3 Global Macular Degeneration Treatment Market by Application
1.3.1 Overview: Global Macular Degeneration Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Others
1.4 Global Macular Degeneration Treatment Market Size & Forecast
1.5 Global Macular Degeneration Treatment Market Size and Forecast by Region
1.5.1 Global Macular Degeneration Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Macular Degeneration Treatment Market Size by Region, (2016-2021)
1.5.3 North America Macular Degeneration Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Macular Degeneration Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Macular Degeneration Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Macular Degeneration Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Macular Degeneration Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Macular Degeneration Treatment Market Drivers
1.6.2 Macular Degeneration Treatment Market Restraints
1.6.3 Macular Degeneration Treatment Trends Analysis
2 Company Profiles
2.1 Bausch Health Companies
2.1.1 Bausch Health Companies Details
2.1.2 Bausch Health Companies Major Business
2.1.3 Bausch Health Companies Macular Degeneration Treatment Product and Solutions
2.1.4 Bausch Health Companies Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bausch Health Companies Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Macular Degeneration Treatment Product and Solutions
2.2.4 Allergan Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Macular Degeneration Treatment Product and Solutions
2.3.4 Novartis Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Macular Degeneration Treatment Product and Solutions
2.4.4 Pfizer Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Macular Degeneration Treatment Product and Solutions
2.5.4 Bayer Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bayer Recent Developments and Future Plans
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Macular Degeneration Treatment Product and Solutions
2.6.4 Roche Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Roche Recent Developments and Future Plans
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Macular Degeneration Treatment Product and Solutions
2.7.4 Sanofi Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Sanofi Recent Developments and Future Plans
2.8 Santen Pharmaceuticals
2.8.1 Santen Pharmaceuticals Details
2.8.2 Santen Pharmaceuticals Major Business
2.8.3 Santen Pharmaceuticals Macular Degeneration Treatment Product and Solutions
2.8.4 Santen Pharmaceuticals Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Santen Pharmaceuticals Recent Developments and Future Plans
2.9 Regeneron Pharmaceuticals
2.9.1 Regeneron Pharmaceuticals Details
2.9.2 Regeneron Pharmaceuticals Major Business
2.9.3 Regeneron Pharmaceuticals Macular Degeneration Treatment Product and Solutions
2.9.4 Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.10 Kanghong Pharma
2.10.1 Kanghong Pharma Details
2.10.2 Kanghong Pharma Major Business
2.10.3 Kanghong Pharma Macular Degeneration Treatment Product and Solutions
2.10.4 Kanghong Pharma Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Kanghong Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Macular Degeneration Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Macular Degeneration Treatment Players Market Share
3.2.2 Top 10 Macular Degeneration Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Macular Degeneration Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Macular Degeneration Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Macular Degeneration Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Macular Degeneration Treatment Revenue Market Share by Application (2016-2021)
5.2 Macular Degeneration Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Macular Degeneration Treatment Revenue by Type (2016-2026)
6.2 North America Macular Degeneration Treatment Revenue by Application (2016-2026)
6.3 North America Macular Degeneration Treatment Market Size by Country
6.3.1 North America Macular Degeneration Treatment Revenue by Country (2016-2026)
6.3.2 United States Macular Degeneration Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Macular Degeneration Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Macular Degeneration Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Macular Degeneration Treatment Revenue by Type (2016-2026)
7.2 Europe Macular Degeneration Treatment Revenue by Application (2016-2026)
7.3 Europe Macular Degeneration Treatment Market Size by Country
7.3.1 Europe Macular Degeneration Treatment Revenue by Country (2016-2026)
7.3.2 Germany Macular Degeneration Treatment Market Size and Forecast (2016-2026)
7.3.3 France Macular Degeneration Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Macular Degeneration Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Macular Degeneration Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Macular Degeneration Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Macular Degeneration Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Macular Degeneration Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Macular Degeneration Treatment Market Size by Region
8.3.1 Asia-Pacific Macular Degeneration Treatment Revenue by Region (2016-2026)
8.3.2 China Macular Degeneration Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Macular Degeneration Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Macular Degeneration Treatment Market Size and Forecast (2016-2026)
8.3.5 India Macular Degeneration Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Macular Degeneration Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Macular Degeneration Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Macular Degeneration Treatment Revenue by Type (2016-2026)
9.2 South America Macular Degeneration Treatment Revenue by Application (2016-2026)
9.3 South America Macular Degeneration Treatment Market Size by Country
9.3.1 South America Macular Degeneration Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Macular Degeneration Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Macular Degeneration Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Macular Degeneration Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Macular Degeneration Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Macular Degeneration Treatment Market Size by Country
10.3.1 Middle East & Africa Macular Degeneration Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Macular Degeneration Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Macular Degeneration Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Macular Degeneration Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Macular Degeneration Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Macular Degeneration Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Macular Degeneration Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Macular Degeneration Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Macular Degeneration Treatment Revenue Market Share by Region (2021-2026)
Table 6. Bausch Health Companies Corporate Information, Head Office, and Major Competitors
Table 7. Bausch Health Companies Major Business
Table 8. Bausch Health Companies Macular Degeneration Treatment Product and Solutions
Table 9. Bausch Health Companies Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Allergan Corporate Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Macular Degeneration Treatment Product and Solutions
Table 13. Allergan Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Macular Degeneration Treatment Product and Solutions
Table 17. Novartis Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Macular Degeneration Treatment Product and Solutions
Table 21. Pfizer Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bayer Corporate Information, Head Office, and Major Competitors
Table 23. Bayer Major Business
Table 24. Bayer Macular Degeneration Treatment Product and Solutions
Table 25. Bayer Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Roche Corporate Information, Head Office, and Major Competitors
Table 27. Roche Major Business
Table 28. Roche Macular Degeneration Treatment Product and Solutions
Table 29. Roche Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Sanofi Corporate Information, Head Office, and Major Competitors
Table 31. Sanofi Major Business
Table 32. Sanofi Macular Degeneration Treatment Product and Solutions
Table 33. Sanofi Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Santen Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. Santen Pharmaceuticals Major Business
Table 36. Santen Pharmaceuticals Macular Degeneration Treatment Product and Solutions
Table 37. Santen Pharmaceuticals Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Regeneron Pharmaceuticals Major Business
Table 40. Regeneron Pharmaceuticals Macular Degeneration Treatment Product and Solutions
Table 41. Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Kanghong Pharma Corporate Information, Head Office, and Major Competitors
Table 43. Kanghong Pharma Major Business
Table 44. Kanghong Pharma Macular Degeneration Treatment Product and Solutions
Table 45. Kanghong Pharma Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Macular Degeneration Treatment Revenue (USD Million) by Players (2019-2021)
Table 47. Global Macular Degeneration Treatment Revenue Share by Players (2019-2021)
Table 48. Breakdown of Macular Degeneration Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Macular Degeneration Treatment Players Head Office, Products and Services Provided
Table 50. Macular Degeneration Treatment Mergers & Acquisitions in the Past Five Years
Table 51. Macular Degeneration Treatment New Entrants and Expansion Plans
Table 52. Global Macular Degeneration Treatment Revenue (USD Million) by Type (2016-2021)
Table 53. Global Macular Degeneration Treatment Revenue Share by Type (2016-2021)
Table 54. Global Macular Degeneration Treatment Revenue Forecast by Type (2021-2026)
Table 55. Global Macular Degeneration Treatment Revenue by Application (2016-2021)
Table 56. Global Macular Degeneration Treatment Revenue Forecast by Application (2021-2026)
Table 57. North America Macular Degeneration Treatment Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Macular Degeneration Treatment Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Macular Degeneration Treatment Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Macular Degeneration Treatment Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Macular Degeneration Treatment Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Macular Degeneration Treatment Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Macular Degeneration Treatment Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Macular Degeneration Treatment Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Macular Degeneration Treatment Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Macular Degeneration Treatment Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Macular Degeneration Treatment Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Macular Degeneration Treatment Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Macular Degeneration Treatment Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Macular Degeneration Treatment Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Macular Degeneration Treatment Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Macular Degeneration Treatment Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Macular Degeneration Treatment Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Macular Degeneration Treatment Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Macular Degeneration Treatment Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Macular Degeneration Treatment Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Macular Degeneration Treatment Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Macular Degeneration Treatment Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Macular Degeneration Treatment Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Macular Degeneration Treatment Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Macular Degeneration Treatment Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Macular Degeneration Treatment Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Macular Degeneration Treatment Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Macular Degeneration Treatment Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Macular Degeneration Treatment Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Macular Degeneration Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Macular Degeneration Treatment Picture
Figure 2. Global Macular Degeneration Treatment Revenue Market Share by Type in 2020
Figure 3. Lucentis
Figure 4. Eylea
Figure 5. Avastin
Figure 6. Others
Figure 7. Macular Degeneration Treatment Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Eye Clinics Picture
Figure 10. Others Picture
Figure 11. Global Macular Degeneration Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Macular Degeneration Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Macular Degeneration Treatment Revenue Market Share by Region (2016-2026)
Figure 14. Global Macular Degeneration Treatment Revenue Market Share by Region in 2020
Figure 15. North America Macular Degeneration Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Macular Degeneration Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Macular Degeneration Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Macular Degeneration Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Macular Degeneration Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Macular Degeneration Treatment Market Drivers
Figure 21. Macular Degeneration Treatment Market Restraints
Figure 22. Macular Degeneration Treatment Market Trends
Figure 23. Bausch Health Companies Recent Developments and Future Plans
Figure 24. Allergan Recent Developments and Future Plans
Figure 25. Novartis Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Bayer Recent Developments and Future Plans
Figure 28. Roche Recent Developments and Future Plans
Figure 29. Sanofi Recent Developments and Future Plans
Figure 30. Santen Pharmaceuticals Recent Developments and Future Plans
Figure 31. Regeneron Pharmaceuticals Recent Developments and Future Plans
Figure 32. Kanghong Pharma Recent Developments and Future Plans
Figure 33. Global Macular Degeneration Treatment Revenue Share by Players in 2020
Figure 34. Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Macular Degeneration Treatment Revenue Market Share in 2020
Figure 36. Global Top 10 Players Macular Degeneration Treatment Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Macular Degeneration Treatment Revenue Share by Type in 2020
Figure 39. Global Macular Degeneration Treatment Market Share Forecast by Type (2021-2026)
Figure 40. Global Macular Degeneration Treatment Revenue Share by Application in 2020
Figure 41. Global Macular Degeneration Treatment Market Share Forecast by Application (2021-2026)
Figure 42. North America Macular Degeneration Treatment Sales Market Share by Type (2016-2026)
Figure 43. North America Macular Degeneration Treatment Sales Market Share by Application (2016-2026)
Figure 44. North America Macular Degeneration Treatment Revenue Market Share by Country (2016-2026)
Figure 45. United States Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Macular Degeneration Treatment Sales Market Share by Type (2016-2026)
Figure 49. Europe Macular Degeneration Treatment Sales Market Share by Application (2016-2026)
Figure 50. Europe Macular Degeneration Treatment Revenue Market Share by Country (2016-2026)
Figure 51. Germany Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Macular Degeneration Treatment Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Macular Degeneration Treatment Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Macular Degeneration Treatment Revenue Market Share by Region (2016-2026)
Figure 59. China Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Macular Degeneration Treatment Sales Market Share by Type (2016-2026)
Figure 66. South America Macular Degeneration Treatment Sales Market Share by Application (2016-2026)
Figure 67. South America Macular Degeneration Treatment Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Macular Degeneration Treatment Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Macular Degeneration Treatment Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Macular Degeneration Treatment Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Macular Degeneration Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

---